AU2000265051A1 - Vasoactive intestinal peptide analogs - Google Patents

Vasoactive intestinal peptide analogs

Info

Publication number
AU2000265051A1
AU2000265051A1 AU2000265051A AU6505100A AU2000265051A1 AU 2000265051 A1 AU2000265051 A1 AU 2000265051A1 AU 2000265051 A AU2000265051 A AU 2000265051A AU 6505100 A AU6505100 A AU 6505100A AU 2000265051 A1 AU2000265051 A1 AU 2000265051A1
Authority
AU
Australia
Prior art keywords
peptide analogs
vasoactive intestinal
intestinal peptide
vasoactive
analogs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2000265051A
Inventor
Neena Gupta
Archna Mathur
Rama Mukherjee
Sudhanand Prasad
Anu T. Singh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dabur Research Foundation
Original Assignee
Dabur Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dabur Research Foundation filed Critical Dabur Research Foundation
Publication of AU2000265051A1 publication Critical patent/AU2000265051A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/17—Vasoactive intestinal peptides; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2000265051A 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs Abandoned AU2000265051A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN136DE2000 2000-02-18
IN136/DEL/2000 2000-02-18
US09/630,335 US6489297B1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs
PCT/US2000/020871 WO2001060862A1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs

Publications (1)

Publication Number Publication Date
AU2000265051A1 true AU2000265051A1 (en) 2001-08-27

Family

ID=26324877

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2000265051A Abandoned AU2000265051A1 (en) 2000-02-18 2000-07-31 Vasoactive intestinal peptide analogs

Country Status (4)

Country Link
US (2) US6489297B1 (en)
EP (1) EP1257576B1 (en)
AU (1) AU2000265051A1 (en)
WO (1) WO2001060862A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433693B (en) 2003-02-14 2014-04-11 Childrens Hosp & Res Ct Oak Lipophilic drug delivery vehicle and methods of use thereof
WO2006106528A1 (en) * 2005-04-07 2006-10-12 Dabur Pharma Limited Novel peptides useful for treatment of alopecia
US20130172274A1 (en) 2005-12-20 2013-07-04 Duke University Methods and compositions for delivering active agents with enhanced pharmacological properties
JP2009525946A (en) 2005-12-20 2009-07-16 デューク・ユニヴァーシティ Methods and compositions for delivering active agents with enhanced pharmacological properties
US8841255B2 (en) 2005-12-20 2014-09-23 Duke University Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
EP2307038A4 (en) 2008-06-27 2013-03-27 Univ Duke Therapeutic agents comprising elastin-like peptides
US8268796B2 (en) 2008-06-27 2012-09-18 Children's Hospital & Research Center At Oakland Lipophilic nucleic acid delivery vehicle and methods of use thereof
BR112012003327A2 (en) 2009-08-14 2017-06-06 Phasebio Pharmaceuticals Inc modified vasoactive intestinal peptides
CA3042620A1 (en) * 2011-02-02 2012-11-29 Emory University Antagonism of the vip signaling pathway
WO2012170524A1 (en) 2011-06-06 2012-12-13 Phasebio Pharmaceuticals, Inc. Use of modified vasoactive intestinal peptides in the treatment of hypertension
US9458217B2 (en) 2013-12-05 2016-10-04 Emory University Methods of managing graft versus host disease
EP3139949B1 (en) 2014-05-08 2020-07-29 Phasebio Pharmaceuticals, Inc. Compositions comprising a vip-elp fusion protein for use in treating cystic fibrosis
CN107427556B (en) 2015-02-09 2022-02-25 费斯生物制药公司 Methods and compositions for treating muscle diseases and disorders
ES2957890T3 (en) 2016-04-08 2024-01-29 Univ Emory Methods for treating cancer and infectious diseases using cell therapies
US11850263B2 (en) 2017-11-10 2023-12-26 Emory University Nanoparticles conjugated with vasoactive intestinal peptide antagonists
US11471506B2 (en) 2018-04-23 2022-10-18 Emory University VIP antagonists and uses in treating cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605641A (en) 1984-10-09 1986-08-12 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
US4734400A (en) 1984-10-09 1988-03-29 Hoffmann-La Roche Inc. Synthetic vasoactive intestinal peptide analogs
GB8525852D0 (en) 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4835252A (en) 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
US5141924A (en) 1989-06-30 1992-08-25 Hoffmann-La Roche, Inc. Synthetic vasoactive intestinal peptide analogs
DE69101187T2 (en) 1990-06-26 1994-09-29 Sanwa Kagaku Kenkyusho Co VIP analogues and their use.
US5217953A (en) * 1990-11-30 1993-06-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Vasoactive intestinal peptide antagonist
US5849261A (en) 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
JPH05238950A (en) 1991-04-22 1993-09-17 Sanwa Kagaku Kenkyusho Co Ltd Readily absorbable vip pharmaceutical
AU656230B2 (en) 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
US5565424A (en) 1994-02-07 1996-10-15 Ramot - University Authority For Applied Research And Industrial Development Ltd. Superactive VIP antagonists
EP0796867B1 (en) * 1995-06-09 2003-11-05 Itoham Foods Inc. Peptide, bronchodilator and blood flow ameliorant
US5955574A (en) 1995-07-13 1999-09-21 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A. Analogs of parathyroid hormone
EP0835662B1 (en) 1996-10-08 2001-11-14 National Institute of Immunology A drug for the treatment of cancer
ATE449789T1 (en) 1998-07-20 2009-12-15 Ipsen Pharma PACAP PEPTIDE ANALOGUE

Also Published As

Publication number Publication date
EP1257576B1 (en) 2004-09-15
WO2001060862A1 (en) 2001-08-23
US20030158110A1 (en) 2003-08-21
US7094755B2 (en) 2006-08-22
EP1257576A1 (en) 2002-11-20
US6489297B1 (en) 2002-12-03

Similar Documents

Publication Publication Date Title
GB0014870D0 (en) Peptides
AU1951201A (en) Peptide antigens
AU2000265051A1 (en) Vasoactive intestinal peptide analogs
AU2002360487A1 (en) Acyclovir-peptide analogs
AU4281999A (en) Peptide
AU2001251321A1 (en) Vancomycin analogs
AU2002222176A1 (en) Time synchronisation
AU2001240791A1 (en) Sequence
HK1042307A1 (en) Peptide having preptin functionality
IL150458A0 (en) Novel haptotactic peptides
PL366425A1 (en) Peptide compounds
GB0001825D0 (en) Peptides
AU6550800A (en) Hepoxilin analogs
EP1312612A4 (en) Cyclic peptide derivative
GB9908920D0 (en) Peptide
AU1552800A (en) Coupled peptides
AU2001278975A1 (en) Alpha-conotoxin peptides
AUPQ386899A0 (en) Peptide compounds
AU2659801A (en) Shc associated protein 140 (sap-140)
GB0007263D0 (en) Peptides
AU5446599A (en) Peptide compounds
AU2001290317A1 (en) Novel peptides
AUPR112700A0 (en) Peptide nitroanilides
AU2002232176A1 (en) Cyclic peptide
AU2002328853A1 (en) Carcinoma-related peptides